Of note, although the proportion of trunk mutations was significantly less than branch mutations in L-FLAC patients, driver gene mutations (oncogene and tumor-suppression gene) were significantly enriched in trunk mutations (P = 0.038; Wilcoxon rank-sum test; Fig. 3e). This evidence concerns the gene ENSG00000280371 and neoplasm.